Search results
Moderna To Present Respiratory & Cytomegalovirus Research at the ESCMID Global Congress
Digital Journal· 5 hours ago...Presenter: Mieke Soens Respiratory Syncytial Virus (RSV) OS102: Coadministration of a respiratory syncytial virus vaccine (mRNA-1345) with an influenza or SARS-CoV-2 vaccine in older adults 1-hour Oral Session, Monday, April 29 - 11:00 (Hall C) Presenter: Jaya Goswami Cytomegalovirus (CMV) P0180:...
COVID Shot Boosts Mucosal Immunity in Previously Infected People
MedPage Today· 2 days agoOnly 'traces' of spike-specific salivary antibodies found in vaccinated SARS-CoV-2-naive people
A one-shot vaccine for COVID, flu and future viruses? Researchers say it's coming
Salon via Yahoo News· 1 week agoBAY ISMOYO/AFP via Getty Images At the beginning of the pandemic, many people hoped that infections...
Big Pharma's Blockbuster Creation Continues to Disappoint
Mercola· 1 day agoMessenger ribonucleic acid (mRNA) vaccines are being described as a "new era in vaccinology."1 Research is underway to develop mRNA shots for not only coronaviruses but also ...
Safety Concerns Put a Stop to Maternal RSV Vaccine Study
Journal of the American Medical Association· 2 weeks agoJournal of Medicine. The data came from a randomized clinical trial involving more than 5000 pregnant people and their infants in 24 countries. About 7% of infants whose birthing ...
Center of Excellence for Serology Development and Emergency Preparedness | Frederick National...
National Cancer Institute· 7 days ago0
COVID-19 Immunity May Last Six Months or More | HHMI
Howard Hughes Medical Institute· 2 weeks agoSix months after infection, those antibodies become both more potent and better at combating mutated versions of the virus, called SARS-CoV-2< ...
Cardiac Events Common in Older, Hospitalized RSV Patients
MedPage Today· 1 week agoNew RSV vaccines could reduce risk, researchers said
Long COVID Leaves A Trace In Blood That Could Be Targeted With Drugs
IFLScience· 2 weeks agoThere’s been some debate around how common the condition is, but many still go by the estimate that...
Are Monoclonal Antibodies the Future of Long COVID Treatments?
Technology Networks· 3 days agoOne study published in PLOS Pathogens in 2022 found that long COVID patients had 100 times the...
